TASSI, RENATO
 Distribuzione geografica
Continente #
EU - Europa 856
NA - Nord America 826
AS - Asia 165
Totale 1.847
Nazione #
US - Stati Uniti d'America 824
PL - Polonia 572
IT - Italia 74
IE - Irlanda 68
CN - Cina 62
SE - Svezia 46
HK - Hong Kong 43
RU - Federazione Russa 29
DE - Germania 28
JO - Giordania 23
SG - Singapore 19
CH - Svizzera 11
VN - Vietnam 8
GB - Regno Unito 7
ES - Italia 6
FI - Finlandia 6
TR - Turchia 6
IN - India 4
AT - Austria 2
BE - Belgio 2
CA - Canada 2
NL - Olanda 2
FR - Francia 1
PT - Portogallo 1
UA - Ucraina 1
Totale 1.847
Città #
Warsaw 570
Fairfield 106
Chandler 92
Ashburn 77
Dublin 68
Cambridge 63
Houston 55
Seattle 53
Wilmington 50
Woodbridge 47
Ann Arbor 32
Beijing 30
Hong Kong 26
Florence 24
Altamura 23
Lawrence 20
Princeton 20
Bremen 16
Buffalo 15
New York 14
Shanghai 14
Boston 12
Singapore 12
Bern 11
Medford 9
Boardman 8
Falls Church 7
Kent 7
Barcelona 6
Dong Ket 6
Phoenix 5
San Diego 5
Los Angeles 4
Moscow 4
Rome 3
Andover 2
Dearborn 2
Frankfurt Am Main 2
Hillsboro 2
Norwalk 2
Pune 2
Radomsko 2
Sesto Fiorentino 2
Toronto 2
Vienna 2
Aprilia 1
Baotou 1
Brussels 1
Castelliri 1
Central District 1
Grevenbroich 1
Izmir 1
Kilburn 1
Kunming 1
Laurel 1
Lisbon 1
Lucca 1
Naaldwijk 1
New Bedfont 1
Oggiono 1
Paceco 1
Philadelphia 1
Poggibonsi 1
Prescot 1
Redmond 1
Rui'an 1
Shenzhen 1
Trumbull 1
Valdobbiadene 1
Wandsworth 1
Washington 1
Totale 1.560
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 248
Emerging drugs in refractory colorectal cancer 232
HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment 226
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 223
Druggable Targets in Pancreatic Adenocarcinoma 200
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 106
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 103
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 89
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 80
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 71
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 65
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 64
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 59
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 57
Sunitinib-induced hyperparathyroidism: A possible mechanism to altered bone homeostasis 38
Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study 31
Totale 1.892
Categoria #
all - tutte 4.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020386 0 45 16 25 51 40 41 46 37 38 37 10
2020/2021284 19 29 2 32 42 34 26 14 24 32 16 14
2021/2022119 3 5 2 6 2 11 3 15 11 8 16 37
2022/2023401 33 71 18 46 27 55 45 25 54 1 6 20
2023/2024154 3 13 18 5 11 23 24 33 1 3 10 10
2024/202551 33 18 0 0 0 0 0 0 0 0 0 0
Totale 1.892